Exagen, Inc. (XGN)
7.58
+0.04
(+0.53%)
USD |
NASDAQ |
Sep 04, 16:00
7.605
+0.02
(+0.33%)
After-Hours: 20:00
Exagen EPS Diluted (TTM) : -0.8057 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.8057 |
| March 31, 2026 | -0.8839 |
| December 31, 2025 | -0.9198 |
| September 30, 2025 | -0.9257 |
| June 30, 2025 | -0.8922 |
| March 31, 2025 | -0.8449 |
| December 31, 2024 | -0.8299 |
| September 30, 2024 | -0.9383 |
| June 30, 2024 | -0.969 |
| March 31, 2024 | -1.090 |
| December 31, 2023 | -1.341 |
| September 30, 2023 | -1.863 |
| June 30, 2023 | -2.031 |
| March 31, 2023 | -2.607 |
| December 31, 2022 | -2.773 |
| September 30, 2022 | -2.354 |
| June 30, 2022 | -2.303 |
| March 31, 2022 | -1.822 |
| December 31, 2021 | -1.698 |
| September 30, 2021 | -1.555 |
| June 30, 2021 | -1.472 |
| March 31, 2021 | -1.359 |
| December 31, 2020 | -1.321 |
| Date | Value |
|---|---|
| September 30, 2020 | -1.320 |
| June 30, 2020 | -12.27 |
| March 31, 2020 | -12.41 |
| December 31, 2019 | -12.37 |
| September 30, 2019 | -12.45 |
| June 30, 2019 | -1.536 |
| March 31, 2019 | -1.493 |
| December 31, 2018 | -1.536 |
| September 30, 2018 | -1.453 |
| June 30, 2018 | -1.422 |
| March 31, 2018 | -1.920 |
| December 31, 2015 | -1.815 |
| September 30, 2015 | -1.814 |
| June 30, 2015 | -1.918 |
| March 31, 2015 | -1.426 |
| December 31, 2014 | -1.428 |
| September 30, 2014 | -1.961 |
| June 30, 2014 | -1.777 |
| March 31, 2014 | -1.650 |
| December 31, 2013 | -1.553 |
| September 30, 2013 | -0.7577 |
| June 30, 2013 | -0.4934 |
| March 31, 2013 | -0.2432 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Myriad Genetics, Inc. | -1.199 |
| BioRestorative Therapies, Inc. | -1.120 |
| CareDx, Inc. | 2.075 |
| Natera, Inc. | -1.368 |
| Sera Prognostics, Inc. | -0.6636 |